healthcare / drug development

Research & Innovation - Padua - Italy Research & Innovation : RESEARCH and INNOVATION RESEARCH and DEVELOPMENT BIOPHARMACEUTICAL COMPANY BIOTECHNOLOGY COMPANY RESEARCH LABORATORIES PHARMACEUTICAL INDUSTRY NEUROBIOLOGY and NEUROPHARMACOLOGY FUNCTIONAL GENOMICS FUNCTIONAL PROTEOMICS NEUROSCIENCE NEUROSCIENZE NEUROLOGICAL DISORDERS DRUG DISCOVERY DRUG DEVELOPMENT NEURODEGENERATIVE DISORDERS...

Oncopharm Corporation is involved in research, development and production of new antileukemic drugs such as homoharringtonine and harringtonine.

Mediolanum farmaceutici is an industrial group, based in Italy with subsidiaries in France and USA, dedicated to the discovery, development and commercialisation of a varied portfolio of products, which include drugs to treat hypertension, vascular disorders, inflammatory diseases, allergies, iron deficiencies, infections, myopia and migraine. Mediolanum's present research is focused on ...

Jerini, as a pharmaceutical company, systematically use the therapeutic potential of peptides to discover and develop novel drugs and is a world market leader in this field.

ICON is a clinical research organisation (CRO) providing clinical research, drug development, regulatory affairs, laboratory services and imaging to the pharmaceutical and biotech industry

Spectrum Pharmaceuticals, Inc. creates value for shareholders through the development of in-licensed drugs for the treatment and supportive care of cancer patients. Satraplatin, is a phase 3 oral, anti-cancer drug. Elsamitrucin, a phase 2 drug, will initially target non-Hodgkin’s lymphoma. Neoquin™ is being studied in the treatment of superficial bladder cancer, and may have ap...

Alchem Laboratories is a custom research organization performing custom synthesis, drug development and cGMP production

Generex is engaged in the research and development of drug delivery technologies and vaccines. Generex’s buccal drug delivery technology, RapidMist™, allows for the non-invasive delivery of small and large molecule drugs typically administered by injection to be absorbed into the mouth as a metered-dose spray, for rapid absorption by the buccal mucosa. Oral-lyn™, Generex’s flagship p...

Cylex manufactures patented in vitro diagnostic products for measuring immune activity (FDA cleared ImmuKnow) in transplant, infectious diseases (e.g., HIV and HCV), cancer, autoimmune disorders, as well as vaccine and drug development.

Penwest is the leading provider of drug delivery technologies that improve patient health by optimizing the performance of medicines.

Provides a neutral global forum for the exchange and dissemination of information on the discovery, development, evaluation and utilization of medicines and related health care technologies.

Nastech Pharmaceutical Company Inc. is an emerging pharmaceutical company dedicated to the development and commercialization of innovative drug delivery technologies and products. The Company's proprietary technologies focus on the delivery of small and large molecule drugs by nasal administration.

GlycoGenesys, Inc. is a biotechnology company developing novel pharmaceutical products based on carbohydrate compounds. This field is called Glycomics and is the latest step after genomics and proteomics in the development of a complete understanding of the human organism. The company's lead drug candidate GCS-100, a potential treatment for multiple forms of cancer, recently completed Ph...

Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development, and commercialization of innovative pharmaceutical products that are directed toward serving unmet medical needs. Sepracor's drug development program has yielded an extensive portfolio of pharmaceutical compounds including candidates for the trea...

HCG is the leader in professional patient recruitment services for clinical trials. We create subject recruitment plans for pharmaceutical companies involved in drug development.

Fertin Pharma is a world leader in the development and manufacture of chewing gum drug delivery systems

Novacea is a privately-held biopharmaceutical company committed to creating a world-class drug development and commercialization organization that addresses the needs of cancer patients who have few treatment options.

Cytochroma Inc. - A Canadian Drug Discovery and Development Company

Gene Logic. Your Partner in Drug Development.

DCAT - The Drug, Chemical & Allied Trades Association - A business development association whose member companies manufacture, distribute or provide services to the drug, chemical, nutritional and related industries.

Curis is a therapeutic drug development company, focusing on regulatory pathways that control repair and regeneration using proteins or small molecules to modulate these pathways.

Cancer Profiler, a solution to personalised Cancer Treatment and rapid development of new cancer drugs. Ipsogen provides oncologists and researchers with a straightforward approach to molecular cancer profiling: molecular diagnostic tools - Associated information systems and prognostic aids - Patented gene expression signatures for each tumour type

Avitar provides a wide range of services to assist in the development, implementation, monitoring, and continuous improvement of a corporate drug testing program.

Taking a different approach to cancer treatment and cancer research through safer, more effective cancer therapies.

Alcon Laboratories online is the most comprehensive online resource for professionals and consumers. Alcon is a worldwide company committed to the discovery, development and manufacture of ophthalmic products and instrumentation. Alcon researches, develops, manufactures, and markets ophthalmic products, including prescription drugs, contact lens solutions, surgical instruments and access...

Resource for professionals in the drug development industry- Information on drug discovery and early-stage drug development, discovery technology and more

Hybridon, Inc. - Drug Development

Microwave Synthesis, Medicinal Chemistry, Lead Optimization & Drug Development

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using two technology platforms: third generation NeuGene(tm) antisense drugs and cancer immunotherapy.

Covance is a comprehensive, biopharmaceutical drug development services company with preclinical and clinical research operations across the globe.

Alexion Pharmaceuticals, Inc. is an acute care and specialty biopharmaceutical company engaged in the development and commercialization of innovative drugs that addresses unmet needs in acute cardiovascular and chronic autoimmune disease areas. Our lead program consists of two monoclonal antibody drugs, pexelizumab in for CABG-CPB and AMI indications, and eculizumab for rheumatoid arthri...

Compugen, a genomics-based drug and diagnostic discovery company, increases the probability of successful development of novel drug and diagnostic products by incorporating ideas and methods from mathematics, computer science, and physics into the disciplines of biology, organic chemistry, and medicine.

Headquartered in Reykjavik, Iceland, deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are p...

DOV Pharmaceutical Inc. is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders.

DURECT Corporation is pioneering the development and commercialization of pharmaceutical drug delivery systems for the treatment of chronic debilitating diseases and to enable biotechnology products.

Exelixis is an integrated drug discovery and development company. Our primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease.

The RegSource Regulatory page is a comprehensive site to information resources for the pharmaceutical professionals. The site provides links to regulatory and scientific information on the Internet for drug discovery, development and the drug approval process. Links are provided to full text information from the Federal Register (FR) and the information in the FR is focused by therapeuti...

Genelabs Technologies, Inc. is a global biopharmaceutical and diagnostics company focused on gene-regulating drug discovery; infectious diseases including hepatitis; and immunological disorders including lupus.

PharmaRegistrations services: licensing, supply, registrations...

Momenta Pharmaceuticals Applying scientific breakthroughs in the understanding of sugars to drug discovery, development and commercialization

Neose is focused on the development of protein therapeutics through the application of its proprietary GlycoAdvance(tm) and GlycoPEGylation(tm) technologies. Neose is also entering into strategic alliances to improve protein drugs being developed by other companies.

Nymox is a development stage biopharmaceuticals company based in Maywood, NJ and St. Laurent, Quebec. Nymox specializes in the research and development of therapeutics and diagnostics for the aging population with an emphasis on Alzheimer's disease.

OXiGENE is a developing, innovative drug company engaged in research and development of anticancer drugs.

Axonyx is a biotechnology company engaged in the discovery, acquisition and development of proprietary pharmaceutical compounds and new technologies useful for the diagnosis and treatment of cognitive disorders including Alzheimer's Disease (AD), a debilitating and fatal disease for which there is no known cure. Axonyx has a portfolio or central nervous system technologies that include f...

Infectious disease and smallpox drug development for biological warfare terrorism. SIGA provides treatment from infectious disease and smallpox drug development for biological warfare.

SIDR identifies early-stage commercial opportunities in drug research, develops them through proof-of-principal stage, and seeks industrial partners for full development.

Biovail is working to develop clinically enhanced, branded versions of a number of existing in-market pharmaceutical compounds. In 2004, these development efforts resulted in the filing of a number of New Drug Applications. These included Tramadol ER (once-daily tramadol), Tramadol ODT, Citalopram ODT and Glumetza™, an extended-release formulation of metformin. In 2005, the Company ...